--- title: Analyze 14.0 Reviews meta_title: 'Analyze 14.0 Reviews 2026: Details, Pricing, & Features | G2' meta_description: Filter reviews by the users' company size, role or industry to find out how Analyze 14.0 works for a business like yours. date_modified: '2026-09-22' parent_category: name: Medical Imaging url: https://www.g2.com/categories/medical-imaging ---

Analyze 14.0 Reviews & Product Details

AnalyzeDirect is a medical imaging software company dedicated to providing applications for the global research community. Our primary product, Analyze, is a powerful, comprehensive software suite for display, processing, segmentation, registration and measurement of biomedical images. Thousands of researchers worldwide use Analyze to quickly and routinely perform visualization and analysis tasks on images from multiple modalities including MR, CT, PET and SPECT.

Seller

Discussions

Analyze 14.0 Community

Top-Rated Alternatives

3D Slicer

Ansys Simpleware

Ansys Simpleware

Invivo5

View All Alternatives

Analyze 14.0 hasn't been reviewed yet

Used Analyze 14.0? Your experience helps thousands of software buyers make confident decisions.

G2 reviews are authentic and verified.

Pricing

Pricing details for this product isn’t currently available. Visit the vendor’s website to learn more.

View More Pricing Information

Work at AnalyzeDirect?

Claim this profile to respond to reviews, update product info, and reach in-market buyers.

Claim this profile

Categories on G2

Medical 3D Visualization

Explore More

Which wide column databases have the best price-to-performance ratio for large-scale OLTP?Microsoft Collaboration Tools Which application shielding tools prevent binary reverse engineering while keeping app launch times fast and the user experience clean?

What are the top sensitive data discovery software with customizable classification rules and data patterns?Best tools for securing data in SaaS applications What sales training tools connect with CRM and sales engagement platforms so reps can see training recommendations based on their actual deal activity?

Show MoreShow Less